ARTICLE | Clinical News
Cobiprostone: Phase IIa discontinued
April 25, 2016 7:00 AM UTC
Sucampo discontinue development of cobiprostone to treat PPI-refractory NERD or sGERD after top-line data from a double-blind Phase IIa trial in 153 patients with PPI-refractory NERD or sGERD showed t...